The group taking ashwagandha showed significantly greater increases in muscle strength and a more pronounced reduction in exercise-induced muscle damage, as indicated by serum creatine kinase levels
For patients interested in participating in research , the following resources may be helpful: NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) search for Parkinson's and GLP-1 trials Parkinson's UK (www.parkinsons.org.uk) information on current research and trial opportunities When to contact your GP or specialist : If you have Parkinson's disease and diabetes, and wish to discuss whether a GLP-1 receptor agonist is appropriate for your diabetes management If you experience new or worsening symptoms whilst taking any medication If you are interested in clinical trial participationyour neurologist can advise on suitable studies Seek urgent medical attention if you experience: Severe, persistent abdominal pain (possible pancreatitis) Persistent vomiting or inability to keep fluids down (risk of dehydration) Signs of dehydration (extreme thirst, dark urine, dizziness) Allergic reaction (rash, swelling, difficulty breathing) Patients should never start, stop, or modify medications without medical supervision
The combined effects could produce excessive sedation or respiratory depression
We will also ask you what youre hoping to achieve from your treatment
The difference between a cloudy vial you can use and one you must discard comes down to timing, temperature, and whether you're willing to trust visual inspection over wishful thinking
.png)
